Synthesis and preclinical evaluation of a selective MET kinase positron emission tomography tracer
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Synthesis and preclinical evaluation of a selective MET kinase positron emission tomography tracer
Authors
Keywords
-
Journal
JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2023-10-23
DOI
10.1002/jlcr.4066
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Recent progress in the imaging of c‐Met aberrant cancers with positron emission tomography
- (2022) Giuseppe Floresta et al. MEDICINAL RESEARCH REVIEWS
- Preclinical evaluation of [18F]cabozantinib as a PET imaging agent in a prostate cancer mouse model
- (2020) Vegard Torp Lien et al. NUCLEAR MEDICINE AND BIOLOGY
- One-step synthesis of [18 F]cabozantinib for use in positron emission tomography imaging of c-Met
- (2017) Vegard Torp Lien et al. JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS
- RON and c-Met facilitate metastasis through the ERK signaling pathway in prostate cancer cells
- (2017) Binbin Yin et al. ONCOLOGY REPORTS
- SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules
- (2017) Antoine Daina et al. Scientific Reports
- Small Molecule Kinase Inhibitors for the Treatment of Brain Cancer
- (2016) Timothy P. Heffron JOURNAL OF MEDICINAL CHEMISTRY
- A historical overview of protein kinases and their targeted small molecule inhibitors
- (2015) Robert Roskoski PHARMACOLOGICAL RESEARCH
- FDA-approved small-molecule kinase inhibitors
- (2015) Peng Wu et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- 2-[18F]Fluoroethyl tosylate – a versatile tool for building 18F-based radiotracers for positron emission tomography
- (2015) Torsten Kniess et al. MedChemComm
- Targeting Receptor Tyrosine Kinase MET in Cancer: Small Molecule Inhibitors and Clinical Progress
- (2013) J. Jean Cui JOURNAL OF MEDICINAL CHEMISTRY
- Bioorthogonal Small Molecule Imaging Agents Allow Single-Cell Imaging of MET
- (2013) Eunha Kim et al. PLoS One
- Molecularly targeted cancer therapy: some lessons from the past decade
- (2013) Min Huang et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Discovery of a Novel Class of Exquisitely Selective Mesenchymal-Epithelial Transition Factor (c-MET) Protein Kinase Inhibitors and Identification of the Clinical Candidate 2-(4-(1-(Quinolin-6-ylmethyl)-1H-[1,2,3]triazolo[4,5-b]pyrazin-6-yl)-1H-pyrazol-1-yl)ethanol (PF-04217903) for the Treatment of Cancer
- (2012) J. Jean Cui et al. JOURNAL OF MEDICINAL CHEMISTRY
- Design, Synthesis, and Structure−Affinity Relationships of RegioisomericN-Benzyl Alkyl Ether Piperazine Derivatives as σ-1 Receptor Ligands
- (2010) Iman A. Moussa et al. JOURNAL OF MEDICINAL CHEMISTRY
- In Vivo Positron Emission Tomography (PET) Imaging of Mesenchymal−Epithelial Transition (MET) Receptor
- (2009) Chunying Wu et al. JOURNAL OF MEDICINAL CHEMISTRY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started